Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Plos One|September 9, 2017
Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptorsSylvie Bretin, Caroline Louis, Laure Seguin, et al.
The Journal of Biological Chemistry|May 23, 2012
Azemiopsin from Azemiops feae viper venom, a novel polypeptide ligand of nicotinic acetylcholine receptorYuri N Utkin, Christoph Weise, Igor E Kasheverov, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
Pentameric ligand-gated ion channel ELIC is activated by GABA and modulated by benzodiazepinesRadovan Spurny, Joachim Ramerstorfer, Kerry Price, et al.
The Journal of Biological Chemistry|January 22, 2011
NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1Ekaterina N Lyukmanova, Zakhar O Shenkarev, Mikhail A Shulepko, et al.
British Journal of Pharmacology|January 11, 2012
A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptorsPhilippe Favreau, Evelyne Benoit, Henry G Hocking, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2010
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodentsTanya L Wallace, Patrick M Callahan, Ashok Tehim, et al.
Nature Chemical Biology|October 9, 2019
A lipid site shapes the agonist response of a pentameric ligand-gated ion channelCamille M Hénault, Cedric Govaerts, Radovan Spurny, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 29, 2005
A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterizationRaymond S Hurst, Mihaly Hajós, Mario Raggenbass, et al.
Frontiers in Pharmacology|August 5, 2025
Preclinical pharmacology of alogabat: a novel GABAA-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABAA signalingGiuseppe Cecere, Theresa M Ballard, Frederic Knoflach, et al.
Pageof 19